Andreas Pihl

No más puestos en curso

65 años

Electronic Technology

Non-Energy Minerals

Consumer Services

Perfil

Andreas Pihl worked as the Chief Operating Officer & Director at Absci Corp.
He was also the Vice President-Operations at Park Corp.
and the Executive Vice President at SUMCO Corp.
Prior to that, he worked as a Quality Unit Manager at General Electric Co. Mr. Pihl received his undergraduate degree from Oregon State University in 1984.

Antiguos cargos conocidos de Andreas Pihl.

Empresas	Cargo	Fin
ABSCI CORPORATION	Director de Operaciones	13/05/2022
Park Corp. Park Corp. SteelNon-Energy Minerals Manufactures machinery and energy components to the steel and energy related industries	Director de Operaciones	01/07/2020
SUMCO CORPORATION	Corporate Officer/Principal	01/01/2004
GE AEROSPACE	Corporate Officer/Principal	01/01/1987

Ver el detalle de la experiencia de Andreas Pihl.

Formación de Andreas Pihl.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andreas Pihl.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
GE Aerospace GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems	Electronic Technology
Park Corp. Park Corp. SteelNon-Energy Minerals Manufactures machinery and energy components to the steel and energy related industries	Non-Energy Minerals
Oregon State University Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SUMCO Corp. SUMCO Corp. Industrial MachineryProducer Manufacturing Manufactures and markets silicon wafers for semiconductors	Producer Manufacturing
Absci Corp. Absci Corp. BiotechnologyHealth Technology Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry	Health Technology